Product
PF-06755992
1 clinical trial
1 indication
Indication
Prostate CancerClinical trial
A PHASE 1 STUDY TO EVALUATE THE SAFETY, PHARMACOKINETICS AND PHARMACODYNAMICS OF ESCALATING DOSES OF A VACCINE-BASED IMMUNOTHERAPY REGIMEN (VBIR) FOR PROSTATE CANCER (PF-06753512)Status: Terminated, Estimated PCD: 2021-02-23